MedTrace Logo

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

NCT01358695 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2013-07-01

No results posted yet for this study

Summary

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

Conditions

  • Lateral Canthal Lines
  • Crow's Feet

Interventions

BIOLOGICAL

ANT-1207

The interventions differ by dose of investigational product applied.

BIOLOGICAL

Botulinum Toxin, Type A

The interventions differ by dose of investigational product applied.

BIOLOGICAL

Botulinum Toxin Type A

The interventions differ by dose of investigational product applied.

Sponsors & Collaborators

  • Anterios Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-02-29
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01358695 on ClinicalTrials.gov